Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler

由 Prime, David, de Backer, Wilfried, Hamilton, Melanie, Cahn, Anthony, Preece, Andrew, Kelleher, Dennis, Baines, Amanda, Moore, Alison, Brealey, Noushin, Moynihan, Jackie
發表在 J Aerosol Med Pulm Drug Deliv (2015)

Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

由 Bardsley, George, Daley-Yates, Peter, Baines, Amanda, Kempsford, Rodger, Williams, Mathew, Mallon, Tony, Braithwaite, Irene, Riddell, Kylie, Joshi, Shashidhar, Bareille, Philippe, Beasley, Richard, Fingleton, James
發表在 Respir Res (2018)